{"id":30162,"date":"2020-10-20T12:00:00","date_gmt":"2020-10-20T12:00:00","guid":{"rendered":"https:\/\/www.euforea.org\/news\/ultimo-ensayo-recovery-sobre-la-covid-19\/"},"modified":"2020-10-20T12:00:00","modified_gmt":"2020-10-20T12:00:00","slug":"ultimo-ensayo-recovery-sobre-la-covid-19","status":"publish","type":"news","link":"https:\/\/www.euforea.org\/es\/news\/ultimo-ensayo-recovery-sobre-la-covid-19\/","title":{"rendered":"\u00daltimo ensayo Recovery sobre la COVID-19"},"content":{"rendered":"<div class=\"paragraph paragraph--text-columns paragraph-id--1214 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<p>Cerca de 40 millones de personas han sido diagnosticadas ya con la enfermedad COVID-19, lo que ha provocado m\u00e1s de un mill\u00f3n de muertes en todo el mundo. La b\u00fasqueda de una vacuna, sin embargo, contin\u00faa a buen ritmo, pero mientras esta sigue siendo una quimera, los tratamientos han mejorado dr\u00e1sticamente, al igual que los resultados de los pacientes. En la Universidad de Oxford, en el Reino Unido, se est\u00e1 llevando a cabo el mayor ensayo del mundo de terapias potenciales (denominado ensayo Recovery), cuyas siglas corresponden a la evaluaci\u00f3n aleatorizada de la terapia contra la COVID-19.  <\/p>\n<p>El profesor Richard Haynes, catedr\u00e1tico de Medicina y coordinador del ensayo Recovery en la Universidad de Oxford, explica que se han reclutado m\u00e1s de 14.000 pacientes en numerosos centros hospitalarios para este ensayo espec\u00edfico. Los pacientes con diagn\u00f3stico confirmado o sospecha de COVID-19 que hab\u00edan sido ingresados en un hospital eran aptos para participar en este ensayo. <\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"paragraph paragraph--text-columns paragraph-id--1215 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<div class=\"video-container\"><center><iframe title=\"Reproductor de v\u00eddeo de YouTube\" src=\"https:\/\/www.youtube.com\/embed\/irc8PzsB2q0?rel=0\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/center><\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Cerca de 40 millones de personas han sido diagnosticadas ya con la enfermedad COVID-19, lo que ha provocado m\u00e1s de un mill\u00f3n de muertes en todo el mundo. La b\u00fasqueda de una vacuna, sin embargo, contin\u00faa a buen ritmo, pero mientras esta sigue siendo una quimera, los tratamientos han mejorado dr\u00e1sticamente, al igual que los resultados de los pacientes. En la Universidad de Oxford, en el Reino Unido, se est\u00e1 llevando a cabo el mayor ensayo del mundo de terapias potenciales (denominado ensayo Recovery), cuyas siglas corresponden a la evaluaci\u00f3n aleatorizada de la terapia contra la COVID-19. El profesor Richard Haynes, catedr\u00e1tico de Medicina y coordinador del ensayo Recovery en la Universidad de Oxford, explica que se han reclutado m\u00e1s de 14.000 pacientes en numerosos centros hospitalarios para este ensayo espec\u00edfico. Los pacientes con diagn\u00f3stico confirmado o sospecha de COVID-19 que hab\u00edan sido ingresados en un hospital eran aptos para participar en este ensayo.<\/p>\n","protected":false},"author":1,"featured_media":30181,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[166],"tags":[167,176,321],"class_list":["post-30162","news","type-news","status-publish","has-post-thumbnail","hentry","category-programas-de-noticias-de-euforea","tag-noticias-de-euforea","tag-profesionales-sanitarios","tag-covid-19"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.5 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>\u00daltimo ensayo Recovery sobre la COVID-19 - EUFOREA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.euforea.org\/news\/ultimo-ensayo-recovery-sobre-la-covid-19\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u00daltimo ensayo Recovery sobre la COVID-19\" \/>\n<meta property=\"og:description\" content=\"Cerca de 40 millones de personas han sido diagnosticadas ya con la enfermedad COVID-19, lo que ha provocado m\u00e1s de un mill\u00f3n de muertes en todo el mundo. La b\u00fasqueda de una vacuna, sin embargo, contin\u00faa a buen ritmo, pero mientras esta sigue siendo una quimera, los tratamientos han mejorado dr\u00e1sticamente, al igual que los resultados de los pacientes. En la Universidad de Oxford, en el Reino Unido, se est\u00e1 llevando a cabo el mayor ensayo del mundo de terapias potenciales (denominado ensayo Recovery), cuyas siglas corresponden a la evaluaci\u00f3n aleatorizada de la terapia contra la COVID-19. El profesor Richard Haynes, catedr\u00e1tico de Medicina y coordinador del ensayo Recovery en la Universidad de Oxford, explica que se han reclutado m\u00e1s de 14.000 pacientes en numerosos centros hospitalarios para este ensayo espec\u00edfico. Los pacientes con diagn\u00f3stico confirmado o sospecha de COVID-19 que hab\u00edan sido ingresados en un hospital eran aptos para participar en este ensayo.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.euforea.org\/news\/ultimo-ensayo-recovery-sobre-la-covid-19\/\" \/>\n<meta property=\"og:site_name\" content=\"EUFOREA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/euforea\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@euforea\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/ultimo-ensayo-recovery-sobre-la-covid-19\\\/\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/ultimo-ensayo-recovery-sobre-la-covid-19\\\/\",\"name\":\"\u00daltimo ensayo Recovery sobre la COVID-19 - EUFOREA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/ultimo-ensayo-recovery-sobre-la-covid-19\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/ultimo-ensayo-recovery-sobre-la-covid-19\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Latest20Recovery20Trial20on20COVID-1920.png\",\"datePublished\":\"2020-10-20T12:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/ultimo-ensayo-recovery-sobre-la-covid-19\\\/#breadcrumb\"},\"inLanguage\":\"es-ES\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.euforea.org\\\/news\\\/ultimo-ensayo-recovery-sobre-la-covid-19\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es-ES\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/ultimo-ensayo-recovery-sobre-la-covid-19\\\/#primaryimage\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Latest20Recovery20Trial20on20COVID-1920.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Latest20Recovery20Trial20on20COVID-1920.png\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/ultimo-ensayo-recovery-sobre-la-covid-19\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/es\\\/elige-tu-camino\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"\u00daltimo ensayo Recovery sobre la COVID-19\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#website\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/\",\"name\":\"EUFOREA\",\"description\":\"Inspiring the Future of Respiratory Care\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.euforea.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es-ES\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#organization\",\"name\":\"EUFOREA\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es-ES\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"width\":500,\"height\":500,\"caption\":\"EUFOREA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/euforea\\\/\",\"https:\\\/\\\/x.com\\\/euforea\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/euforea\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/EUFOREA\",\"https:\\\/\\\/www.instagram.com\\\/euforeaofficial\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"\u00daltimo ensayo Recovery sobre la COVID-19 - EUFOREA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.euforea.org\/news\/ultimo-ensayo-recovery-sobre-la-covid-19\/","og_locale":"es_ES","og_type":"article","og_title":"\u00daltimo ensayo Recovery sobre la COVID-19","og_description":"Cerca de 40 millones de personas han sido diagnosticadas ya con la enfermedad COVID-19, lo que ha provocado m\u00e1s de un mill\u00f3n de muertes en todo el mundo. La b\u00fasqueda de una vacuna, sin embargo, contin\u00faa a buen ritmo, pero mientras esta sigue siendo una quimera, los tratamientos han mejorado dr\u00e1sticamente, al igual que los resultados de los pacientes. En la Universidad de Oxford, en el Reino Unido, se est\u00e1 llevando a cabo el mayor ensayo del mundo de terapias potenciales (denominado ensayo Recovery), cuyas siglas corresponden a la evaluaci\u00f3n aleatorizada de la terapia contra la COVID-19. El profesor Richard Haynes, catedr\u00e1tico de Medicina y coordinador del ensayo Recovery en la Universidad de Oxford, explica que se han reclutado m\u00e1s de 14.000 pacientes en numerosos centros hospitalarios para este ensayo espec\u00edfico. Los pacientes con diagn\u00f3stico confirmado o sospecha de COVID-19 que hab\u00edan sido ingresados en un hospital eran aptos para participar en este ensayo.","og_url":"https:\/\/www.euforea.org\/news\/ultimo-ensayo-recovery-sobre-la-covid-19\/","og_site_name":"EUFOREA","article_publisher":"https:\/\/www.facebook.com\/euforea\/","twitter_card":"summary_large_image","twitter_site":"@euforea","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.euforea.org\/news\/ultimo-ensayo-recovery-sobre-la-covid-19\/","url":"https:\/\/www.euforea.org\/news\/ultimo-ensayo-recovery-sobre-la-covid-19\/","name":"\u00daltimo ensayo Recovery sobre la COVID-19 - EUFOREA","isPartOf":{"@id":"https:\/\/www.euforea.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.euforea.org\/news\/ultimo-ensayo-recovery-sobre-la-covid-19\/#primaryimage"},"image":{"@id":"https:\/\/www.euforea.org\/news\/ultimo-ensayo-recovery-sobre-la-covid-19\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Latest20Recovery20Trial20on20COVID-1920.png","datePublished":"2020-10-20T12:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.euforea.org\/news\/ultimo-ensayo-recovery-sobre-la-covid-19\/#breadcrumb"},"inLanguage":"es-ES","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.euforea.org\/news\/ultimo-ensayo-recovery-sobre-la-covid-19\/"]}]},{"@type":"ImageObject","inLanguage":"es-ES","@id":"https:\/\/www.euforea.org\/news\/ultimo-ensayo-recovery-sobre-la-covid-19\/#primaryimage","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Latest20Recovery20Trial20on20COVID-1920.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Latest20Recovery20Trial20on20COVID-1920.png","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/www.euforea.org\/news\/ultimo-ensayo-recovery-sobre-la-covid-19\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/www.euforea.org\/es\/elige-tu-camino\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.euforea.org\/news\/"},{"@type":"ListItem","position":3,"name":"\u00daltimo ensayo Recovery sobre la COVID-19"}]},{"@type":"WebSite","@id":"https:\/\/www.euforea.org\/#website","url":"https:\/\/www.euforea.org\/","name":"EUFOREA","description":"Inspiring the Future of Respiratory Care","publisher":{"@id":"https:\/\/www.euforea.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.euforea.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es-ES"},{"@type":"Organization","@id":"https:\/\/www.euforea.org\/#organization","name":"EUFOREA","url":"https:\/\/www.euforea.org\/","logo":{"@type":"ImageObject","inLanguage":"es-ES","@id":"https:\/\/www.euforea.org\/#\/schema\/logo\/image\/","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","width":500,"height":500,"caption":"EUFOREA"},"image":{"@id":"https:\/\/www.euforea.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/euforea\/","https:\/\/x.com\/euforea","https:\/\/www.linkedin.com\/company\/euforea","https:\/\/www.youtube.com\/c\/EUFOREA","https:\/\/www.instagram.com\/euforeaofficial\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/news\/30162","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/comments?post=30162"}],"version-history":[{"count":0,"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/news\/30162\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/media\/30181"}],"wp:attachment":[{"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/media?parent=30162"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/categories?post=30162"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euforea.org\/es\/wp-json\/wp\/v2\/tags?post=30162"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}